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Prior to the development of a disease, Preventive Medi-
cine enables early detection of signs and symptoms of
diseases; if logical measures are taken, an outbreak
i.e the development of a disease may possibly be avoided.
If the possibility of curing a disease is missed, only the
treatment and relief of symptoms remains. The disease
becomes incurable and chronic. Since the healing of ser-
ious illnesses is only effective as long as the patient is not
yet seriously affected, the concept of healing should be
redefined. Thus, the removal of a small tumor, the
patient hasn’t yet noticed, could be considered to fall into
the category of preventive medicine (see Figure 1). The
basic principle can be illustrated particularly well by the
example of a tumor, but applies to all diseases. It follows,
that prevention, i.e. the early detection of disease, is the
most effective method to combat disease. Since many
predisposing factors for disease development are already
defined during embryonic development, a lot of time is
left to carry out successful prevention.
Modern preventive medicine makes use of all techni-
cal means of modern diagnostics - from the extensive
history up to detailed genetic investigations. It examines
all relevant organ systems according to the WHO
(World Health Organization) defined hierarchical table
of the most common life-threatening causes of diseases.
Physical exams - with the help of equipment - allow an
assessment of a patient’s condition at the time of the
investigation.
Sustainability, that is the period for which the test
results are valid, can be estimated from the results of
such studies and from the observation period of the
study. Since there is no scientific advantages or post-
closure plan for many diseases, routine follow-up exami-
nation are usually scheduled at set, agreed upon intervals,
e.g. once a year.
If a more accurate assessment of the disease risk in
healthy patients is desired or the prognosis of a particular
course of a known disease with known genetic factors
favoring the disease is suspected, genetically predisposing
factors should be checked. This is done by means of
molecular genetic testing of possibly afflicted genes in the
DNA of the patient. After creating an exact genetic fin-
gerprint, worldwide comparisons of the genetic finger-
prints among patients with the same or similar changes
can be performed and conclusions can be drawn and pre-
dictions can be made.
High quality laboratory equipment allows both tar-
geted hotspot analysis (using the Sanger sequencing) as
well as screening tests on several hundred genes (using
the panel study of next-generation sequencing).
For the screening tests, validated predisposing-genes
are examined for the following disease groups:
a.) Heart and vascular diseases
b.) Tumors
c.) Metabolic diseases
d.) Diseases of bones and connective tissues
e.) Diseases of the sense organs
f.) Neurodegenerative Diseases
g.) Organ and systemic diseases
h.) Blood diseases
The use of molecular genetic studies is subject to
strict guidelines that are laid down in the so-called
Gene-Diagnosis-Law. For this reason, human genetic
consultations are prescribed by a specialist in human
genetics before performing predictive diagnostics on
healthy patients. Human genetic counseling before pro-
ceeding with the diagnostic methods may be omitted if
there is the suspicion of a genetically determined disease
upon physical or other examinations.
The overall concept includes subtle diagnostic meth-
ods in molecular medicine, particularly translational
research techniques which have not yet become stan-
dard in the medical routine examinations. Therefore, we
have coined the term “molecular prevention” for it.
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Examination of the leg arteries
(Pulse oscillography)
Bone density measurements
Eye examinations vision control
Ocular pressure
Photograph of the fundus
Ocular coherence tomography
Optional




Figure 1 Concept - pathogenesis of renal cell cancer. Vulnerable residual stem cells, which, after being inflicted by damaging effects, do not have
appropriate repair mechanisms and are therefore transformed into so-called tumor stem cells. In the presented model, the vulnerability of the cells
is already genetically determined and thus theoretically predictable. After initiation of tumor growth, healing can only be achieved if no significant
metastasis has occurred and later through the removal of the tumor. Partial control of metastasis by the body’s immune system is suspected.
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Long-term glucose measurement
Cardiac MRI as a non-invasive coronary-diagnostic
measure
Genetic testing for disease genes
Duration of basic checks: about 3.5 hours.
Personalized conclusions from the findings
For each patient, a wealth of research data is generated
that allows the development of a personalized strategy.
However, the analysis of data allows not only the deter-
mination of a precise medical treatment strategy, but
also the precise definition of reasonable care intervals,
the observance makes a continuous monitoring of dis-
ease development / progress possible. In addition, the
data serves as a basis for life style consultation to avoid
specific hazards for which the body of the individual
patient holds inadequate compensation mechanisms.
Personalized exercise and nutrition concepts help
patients to remain healthy.
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